Sunitinib: a multitargeted receptor tyrosine kinase inhibitor in the era of molecular cancer therapies

GS Papaetis, KN Syrigos - BioDrugs, 2009 - Springer
Sunitinib is an oral oxindole multitargeted kinase inhibitor that inhibits certain receptor
tyrosine kinases (RTKs). These include vascular endothelial growth factor receptors (VEGFR …
被引用次数：229 相关文章

Sunitinib: a multitargeted receptor tyrosine kinase inhibitor in the era of molecular cancer therapies

GS Papaetis, KN Syrigos - … , biopharmaceuticals and gene …, 2009 - pubmed.ncbi.nlm.nih.gov
Sunitinib is an oral oxindole multitargeted kinase inhibitor that inhibits certain receptor
tyrosine kinases (RTKs). These include vascular endothelial growth factor receptors (VEGFR …

Sunitinib.

GS Papaetis, KN Syrigos - BioDrugs, 2009 - search.ebscohost.com
Sunitinib is an oral oxindole multitargeted kinase inhibitor that inhibits certain receptor
tyrosine kinases (RTKs). These include vascular endothelial growth factor receptors (VEGFR …

Sunitinib

GS Papaetis, KN Syrigos - BioDrugs, 2009 - infona.pl
Sunitinib is an oral oxindole multitargeted kinase inhibitor that inhibits certain receptor
tyrosine kinases (RTKs). These include vascular endothelial growth factor receptors (VEGFR …

Sunitinib

GS Papaetis, KN Syrigos - BioDrugs, 2009 - search.proquest.com
Sunitinib is an oral oxindole multitargeted kinase inhibitor that inhibits certain receptor
tyrosine kinases (RTKs). These include vascular endothelial growth factor receptors (VEGFR …
[PDF] researchgate.net

[PDF][PDF] A Multitargeted Receptor Tyrosine Kinase Inhibitor in the Era of Molecular Cancer Therapies

GS Papaetis, KN Syrigos - Biodrugs, 2009 - researchgate.net
Sunitinib is an oral oxindole multitargeted kinase inhibitor that inhibits certain receptor
tyrosine kinases (RTKs). These include vascular endothelial growth factor receptors (VEGFR …

Sunitinib: a multitargeted receptor tyrosine kinase inhibitor in the era of molecular cancer therapies.

GS Papaetis, KN Syrigos - Biodrugs: Clinical Immunotherapeutics …, 2009 - europepmc.org
Sunitinib is an oral oxindole multitargeted kinase inhibitor that inhibits certain receptor
tyrosine kinases (RTKs). These include vascular endothelial growth factor receptors (VEGFR …

[引用][C] Sunitinib

GS Papaetis, KN Syrigos - BioDrugs, 2009 - cir.nii.ac.jp

Sunitinib: a multitargeted receptor tyrosine kinase inhibitor in the era of molecular cancer therapies

GS Papaetis, KN Syrigos - BioDrugs, 2009 - hero.epa.gov
Sunitinib is an oral oxindole multitargeted kinase inhibitor that inhibits certain receptor
tyrosine kinases (RTKs). These include vascular endothelial growth factor receptors (VEGFR …

Sunitinib: a multitargeted receptor tyrosine kinase inhibitor in the era of molecular cancer therapies

GS Papaetis, KN Syrigos - BioDrugs, 2009 - go.gale.com
Sunitinib is an oral oxindole multitargeted kinase inhibitor that inhibits certain receptor
tyrosine kinases (RTKs). These include vascular endothelial growth factor receptors (VEGFR …